个人简介
Lidija Antunovic医生是米兰IRCCS San Raffaele医院核医学科的核医学专家,由Arturo Chiti教授领导。
2004年,她在帕多瓦大学医学院获得医学与外科学学位。2010年,她在同一大学完成了核医学专业培训。2019年,她在Hunimed完成了临床流行病学高级课程。
她的临床活动专注于利用传统核医学方法进行诊断,特别关注炎症性疾病和感染,以及PET/CT和PET/MRI技术。在肿瘤和非肿瘤研究中,她使用多种PET放射性药物:18F-FDG、11C-胆碱、11C-甲硫氨酸、68Ga-Dotatoc、18F-FET、18F-DOPA、18F-氟化物、124I-Na、18F-PSMA、68Ga-PSMA。
她为患有甲状腺良性和恶性疾病、前列腺癌和神经内分泌肿瘤的患者提供门诊服务。她还进行甲状腺功能亢进症的放射代谢治疗(门诊)、住院放射代谢治疗(甲状腺、前列腺、神经内分泌肿瘤)以及骨转移放射代谢治疗(前列腺癌和乳腺癌)。
她的研究活动集中在肺部和乳腺肿瘤。她利用人工智能算法进行先进的图像分析,参与骨骼感染研究项目,并且是欧洲核医学协会(EANM)骨与关节委员会的成员。
出版物
最新出版物
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Blood pool phase SPECT: the missing link of bone scintigraphy
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
EANM Bone & Joint Committee, the Dosimetry Committee, the Oncology & Theranostics Committee.The EANM guideline for radiosynoviorthesis
PET/CT radiomics in breast cancer: Mind the step
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics
[18F]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
Eur J Nucl Med Mol Imaging. 2017 Sep 24. doi: 10.1007/s00259-017-3837-7.
[18F]FDG PET/CT features for the molecular characterisation of primary breast tumours
Eur J Nucl Med Mol Imaging. 2017;44:1945-1954. (DOI 10.1007/s00259-017-3770-9).
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
Sci Rep. 2017;23;7:358. (DOI: 10.1038/s41598-017-00426-y)